ArticleToxicological sciences : an official journal of the Society of Toxicology2026
Integrating mechanistic data to contextualize in vivo apical observations using the developmental neurotoxicity in vitro battery.
Article in Toxicological sciences : an official journal of the Society of Toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Regulatory toxicity studies traditionally rely on in vivo apical endpoints for hazard characterization and risk assessment; when available, relevant and reliable in vitro assays are anticipated to aid this interpretation. Developmental neurotoxicity (DNT)-related parameters such as brain morphometry can be especially challenging to interpret, based on technical challenges such as sample preparation artifacts. This study employed the Developmental Neurotoxicity In Vitro Battery (DNT-IVB), designed to provide functional insights on key neurodevelopmental processes (KNDPs), to provide context for equivocal brain morphometry effects observed in a legacy in vivo DNT study conducted with acibenzolar-S-methyl (ASM), a plant host defense inducer. ASM and its major mammalian metabolite, acibenzolar acid (AA), were tested in all 17 in vitro assays comprised within the current iteration of the DNT-IVB. In vitro testing concentrations were derived to match the existing in vivo DNT study by applying physiologically based pharmacokinetic (PBPK) modeling with adjustment for rat versus human toxicokinetics. All concentration-response DNT-IVB assay data were analyzed using the US EPA ToxCast Pipeline. ASM showed no effect on any KNDP in vitro. AA was active only in the rat network formation assay with low potency AC50 ranges of 96.1 to 150 µM that modeling shows will not be achieved in vivo at doses where the apical effects in question were observed. This case study demonstrates the potential of the DNT-IVB to be used as a tool to assess equivocal findings from in vivo DNT studies and contribute to a weight of evidence to support conclusions on chemical-mediated DNT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.